Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

PURPOSE: The primary objective of this study was to assess long-term safety with sublingual asenapine 2.5 or 5 mg twice daily (BID) in patients with schizophrenia. PATIENTS AND METHODS: Actively treated patients on asenapine 2.5 mg BID, asenapine 5 mg BID, or olanzapine 15 mg once daily (QD) who com...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuropsychiatr Dis Treat
Huvudupphovsmän: Durgam, Suresh, Landbloom, Ronald P, Mackle, Mary, Wu, Xiao, Mathews, Maju, Nasrallah, Henry A
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2017
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546824/
https://ncbi.nlm.nih.gov/pubmed/28814871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S130211
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk